Wednesday, February 10, 2010, 6:55am EST - Canadian Markets open in 2 hours and 35 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

OSI Pharmaceuticals Inc. (OSIP)

 On Feb 9: 34.18 USD   0.00 (0.00%)  
MORE ON OSIP
Quotes
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
HereIncome Statement
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 30-Sep-07 30-Jun-07 31-Mar-07 31-Dec-06
Total Revenue 100,370   78,883   77,469   83,286  
Cost of Revenue 2,142   2,047   1,904   34,447  
Gross Profit 98,228   76,836   75,565   48,839  
Operating Expenses
Research Development 29,489   27,269   30,626   43,589  
Selling General and Administrative 24,816   24,038   25,129   40,683  
Non Recurring 7,500   -   -   185,724  
Others 461   459   458   4,982  
Total Operating Expenses 62,266   -   -   274,978  
Operating Income or Loss 35,962   25,070   19,352   (226,139)
Income from Continuing Operations
Total Other Income/Expenses Net 1,753   6,015   2,146   4,902  
Earnings Before Interest And Taxes 37,715   31,085   21,498   (221,237)
Interest Expense 1,811   1,809   1,803   1,906  
Income Before Tax 35,904   29,276   19,695   (223,143)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops 35,904   29,276   19,695   (223,143)
Non-recurring Events
Discontinued Operations (6,276) (9,654) (13,054) -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 29,628   19,622   6,641   (223,143)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares $29,628   $19,622   $6,641   ($223,143)

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Income Statement for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices


Reuters offers more in-depth Company Research , Stock Screening , and Risk Alerts on over 10,000 U.S. Equities.